Hemispherx Biopharma Inc (NYSE American:HEB)

0.5277
Delayed Data
As of 4:10pm ET
 +0.0427 / +8.80%
Today’s Change
0.30
Today|||52-Week Range
0.84
+52.51%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Hemispherx Biopharma Inc have a median target of 17.40, with a high estimate of 17.40 and a low estimate of 17.40. The median estimate represents a +3,197.33% increase from the last price of 0.53.

Analyst Recommendations

There are no recommendations available.

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
--
Sales
-$32.8B
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually 65,548.35%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.